You are here
One-year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26-week extension to a 26-week main trial
Gough SC, Bode BW, Woo VC, Rodbard HW, Linjawi S, Zacho M, Reiter PD, Buse JB
Diabetes, Obesity and Metabolism 17: 965–973, 2015.
Developed by Elsevier B.V., supported by an unrestricted educational grant from Novo Nordisk